• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Veradigm Acquires Koha Health to Strengthen Ambulatory RCM

Share:

January 9, 2024

Veradigm, a healthcare tech solutions provider, has acquired Koha Health, a revenue cycle management (RCM) company, enhancing its RCM services in ambulatory healthcare. This strategic move expands Veradigm’s expertise, particularly in Musculoskeletal Medicine (MSK), broadening its client scope to include diverse EHR systems and Ambulatory Surgical Centers (ASCs). The acquisition strengthens Veradigm’s end-to-end RCM offerings, aiming for growth and improved services for partner healthcare providers.

What You Should Know:

– Veradigm Inc. (NASDAQ: MDRX), a leading healthcare data and technology solutions provider, announced today the acquisition of Koha Health, a full-service revenue cycle management (RCM) company.

– This strategic move strengthens Veradigm’s position as a premier provider of RCM services in the ambulatory healthcare market. Financial details of the acquisition were not dislcosed.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Expanding Ambulatory RCM Expertise and Reach

The acquisition brings significant advantages for both companies:

Enhanced MSK Expertise: Koha’s specialized knowledge in Musculoskeletal Medicine (MSK) adds depth and breadth to Veradigm’s RCM offerings, catering to a growing and crucial healthcare sector.

Widened Service Scope: Veradigm gains the ability to serve a broader range of clients, including ambulatory healthcare provider practices and Ambulatory Surgical Centers (ASCs) utilizing diverse EHR systems.

End-to-End RCM Portfolio: Veradigm bolsters its RCM suite, providing clients with a comprehensive solution encompassing the entire revenue cycle, from claims management to reimbursement.

This move not only strengthens Veradigm’s existing client base but also unlocks new market opportunities, particularly in the MSK and diverse EHR segments. By providing clients with added value through a comprehensive and specialized RCM solution, Veradigm aims to drive growth and success for both the company and its partner healthcare providers.

“Today’s announcement represents an exciting opportunity for Veradigm to scale our revenue cycle services portfolio by leveraging additional capabilities and subject matter expertise to better serve the needs of the market,” said Tom Langan, President, and Chief Commercial Officer at Veradigm.

Source: Hit Consultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Blade Therapeutics Expands Anti-Fibrotic Pipeline With Acquisition of ATXCo and Its Autotaxin Inhibitor (PAT-409)Blade Therapeutics Expands Anti-Fibrotic Pipeline With Acquisition of ATXCo and Its Autotaxin Inhibitor (PAT-409)
  • Eurofins Discovery Announces Acquisition of DiscoveryBioMedEurofins Discovery Announces Acquisition of DiscoveryBioMed
  • Insights on Precision Oncology Developments in Japan and BeyondInsights on Precision Oncology Developments in Japan and Beyond
  • Telehealth Service Providing Mail-Order Menopause Hormone Replacement Therapies LaunchesTelehealth Service Providing Mail-Order Menopause Hormone Replacement Therapies Launches
  • Rite Aid’s New CEO, CommonSpirit Health Appoints First Chief Information and Digital Officer, Geisinger’s Chief Nursing Exec, Other Health IT AppointmentsRite Aid’s New CEO, CommonSpirit Health Appoints First Chief Information and Digital Officer, Geisinger’s Chief Nursing Exec, Other Health IT Appointments
  • Aeglea BioTherapeutics Announces Acquisition of Spyre Therapeutics.Aeglea BioTherapeutics Announces Acquisition of Spyre Therapeutics.
  • Eyeing Healthcare Providers, Microsoft Updates Its Team Coordination Platform with Interoperable EHR Support, Messaging FeaturesEyeing Healthcare Providers, Microsoft Updates Its Team Coordination Platform with Interoperable EHR Support, Messaging Features
  • Bio-Techne Completes Acquisition of Asuragen, Inc.Bio-Techne Completes Acquisition of Asuragen, Inc.

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications